| Literature DB >> 34124779 |
Antoine Jaquet1, Simon P Boni2,3, Kouakou Boidy4, Judicaël Tine5, Boris Tchounga3,6, Sokhna A Touré7, Jean-Jacques Koffi3, Cherif Dial8, Alain Monnereau1, Isidore Diomande9, Aristophane Tanon10, Moussa Seydi5, François Dabis1, Saliou Diop7, Gustave Koffi4.
Abstract
Non-Hodgkin lymphomas (NHL) are underestimated causes of cancer in West Africa where chronic viral hepatitis and HIV are endemic. While the association with HIV infection has already been characterized, limited information is available on the association between chronic viral hepatitis and NHL in sub-Saharan Africa. A case-control study was conducted in referral hospitals of Abidjan (Cote d'Ivoire) and Dakar (Senegal). Cases of NHL were matched with controls on age, gender and participating site. The diagnosis of NHL relied on local pathological examination completed with immunohistochemistry. HIV, HBV and HCV serology tests were systematically performed. A conditional logistic regression model estimated the associations by the Odds Ratio (OR) with their 95% confidence interval (CI). A total of 117 NHL cases (Abidjan n = 97, Dakar n = 20) and their 234 matched controls were enrolled. Cases were predominantly men (68.4%) and had a median age of 50 years (IQR 37-57). While Diffuse Large B-cell lymphoma were the most reported morphological type (n = 35) among mature B-cell NHL, the proportion mature T-cell NHL (30%) was high. The prevalence figures of HBV, HCV and HIV infection were 12.8%, 7.7% and 14.5%, respectively among cases of NHL. In multivariate analysis, HBV, HCV and HIV were independently associated with NHL with OR of 2.23 (CI 1.05-4.75), 4.82 (CI 1.52-15.29) and 3.32 (CI 1.54-7.16), respectively. Chronic viral hepatitis B and C were significantly associated with NHL in West Africa. Timely preventive measures against HBV infection and access to curative anti-HCV treatment might prevent a significant number of NHL.Entities:
Keywords: Africa; HBV; HCV; HIV/AIDS; epidemiology; non-Hodgkin lymphoma
Mesh:
Year: 2021 PMID: 34124779 PMCID: PMC8486336 DOI: 10.1002/ijc.33709
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.316